Travere Therapeutics, Inc. 4

Chief Medical Officer Jula Inrig gifted 468 shares of Travere Therapeutics, Inc. common stock to a donor-advised fund.

On June 22, 2026, Travere Therapeutics, Inc. Chief Medical Officer Jula Inrig made a bona fide charitable gift of 468 shares of Travere Therapeutics common stock to a donor-advised fund, a non-cash transfer coded as a gift on Form 4. The transaction did not involve any purchase or sale for consideration and therefore does not represent a change in the insider’s economic view of the stock, but it does slightly reduce her direct holdings. Following the gift, Inrig directly owns 112,770 shares of Travere Therapeutics common stock. The gift was authorized on June 16, 2026, with the transfer completed on June 22, 2026.

Filing Facts

CIK

1438533

Ticker

TVTX

Form

4

Source Type

sec

Accession

0001902368-26-000007

Alert Tier

4